EUVIMEDEUVIMED entdecken
LeserbriefFallbericht

Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane‐based regimens

Shigeru Koizumi iD, Reiichi Doi, Urara Aitake, Xiaofeng Lei, Teruaki Izumi, Tatsuhiko Mori, Naoko Shojiguchi, Tomonori Kawasaki, Takashi Inozume iD, Akiko Kishi

The Journal of Dermatology · 2024

DOI: 10.1111/1346-8138.17101 ↗

Kurz gefasst

Leserbrief in der Zeitschrift The Journal of Dermatology, 2024. Verfasst von Shigeru Koizumi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan. Hauptthemen laut MEDLINE: Paget Disease, Extramammary, Antibodies, Monoclonal, Humanized, Mutation, Taxoids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Paget Disease, ExtramammaryAntibodies, Monoclonal, HumanizedMutationTaxoidsHumansSkin NeoplasmsMaleAgedFemaleAntineoplastic Combined Chemotherapy ProtocolsTreatment FailureAntineoplastic Agents, Immunological

Substanzen

Antibodies, Monoclonal, HumanizedpembrolizumabTaxoidsAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Department of Dermatology, Chiba University, Chiba, Japan.
  • Department of Pathology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Department of Dermatology, Toranomon Hospital, Tokyo, Japan.

ORCID-Profile: Shigeru Koizumi, Takashi Inozume

Zitieren

APA

Koizumi, S., Doi, R., Aitake, U., Lei, X., Izumi, T., Mori, T., Shojiguchi, N., Kawasaki, T., Inozume, T., & Kishi, A. (2024). Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane‐based regimens. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17101

Vancouver

Koizumi S, Doi R, Aitake U, Lei X, Izumi T, Mori T, et al. Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane‐based regimens. The Journal of Dermatology. 2024. doi:10.1111/1346-8138.17101

BibTeX
@article{Koizumi2024,
  author = {Koizumi, Shigeru and Doi, Reiichi and Aitake, Urara and Lei, Xiaofeng and Izumi, Teruaki and Mori, Tatsuhiko and Shojiguchi, Naoko and Kawasaki, Tomonori and Inozume, Takashi and Kishi, Akiko},
  title = {Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane‐based regimens},
  journal = {The Journal of Dermatology},
  year = {2024},
  doi = {10.1111/1346-8138.17101}
}
Kostenlos starten →